1 / 1

Cenobamat(Xcopri)

Acetylcysteine Injection, FLUIMUCIL, Acetylcysteine InjectionAcetylcysteine Injection, FLUIMUCIL, Acetylcysteine InjectionAcetylcysteine Injection, FLUIMUCIL, Acetylcysteine Injection

Reference price:

Manufacturer:

SK LIFE

Formulation:

TABLET

Validity period:

24 months

Reminder: The outer packaging is for reference only, please purchase and use under the guidance of a pharmacist. For read by medical and pharmaceutical professionals only.

Xcopri(Cenobamat) Instructions:Uses,Dosage, Side Effects

Cenobamate is a medication used in the management of partial-onset seizures in adults. It works by modulating both sodium channels and GABA receptors in the brain, making it effective in reducing the frequency of seizures. The drug is known for its high bioavailability and is typically administered orally.

The treatment begins with a low dose, which is titrated gradually. Its safety profile includes potential risks such as QT interval shortening and somnolence, so careful monitoring is advised. It is not recommended for individuals with certain heart conditions, such as familial short QT syndrome.

This manual consolidates the key details regarding Cenobamate from the available documentation.

Generic name

Cenobamat(Xcopri)

English name

Cenobamat

Alternative Names

Xcopri

Drug prices

Indications

XCOPRI is indicated for the treatment of partial-onset seizures in adult patients. It is used to help reduce the frequency and severity of seizures in individuals suffering from epilepsy characterized by partial-onset seizures.

Therapeutic Target

epileptic neuronal circuits

Active Ingredients

Cenobamate

Dosage form

TABLET

specifications

25mg*30 tablets/box

Description

XCOPRI (Cenobamate) is an antiepileptic drug (AED) developed to treat partial-onset seizures in adults. It has a dual mechanism of action: it enhances GABAergic inhibition and inhibits sodium channel activity, both of which help to stabilize neuronal firing and reduce the likelihood of seizures. The drug has demonstrated efficacy in clinical trials, showing significant seizure reduction in patients with partial-onset epilepsy.

Dosage and Administration

The recommended initial dosage is 12.5 mg once daily, which can be titrated upward to a maintenance dose of 200 mg once daily.

CATEGORY NAVIGATION

RECOMMENDED ARTICLES

Adverse Reactions of Cenobamat

Cenobamat is a medication indicated for the treatment of partial-onset seizures in adult patients. While it...

Friday, January 23rd, 2026, 11:26

What are the Precautions for Cenobamat Administration?

Cenobamat is an antiepileptic drug indicated for the treatment of partial-onset seizures in adults. As a novel...

Friday, January 23rd, 2026, 11:23

Dosage and Administration of Cenobamat: Recommended Dosage

Cenobamat is a prescription medication indicated for the treatment of focal-onset seizures in adult patients....

Friday, January 23rd, 2026, 10:45

What Are the Indications for Cenobamat?

Cenobamat is an oral antiepileptic drug primarily indicated for the treatment of partial-onset seizures in adults....

Thursday, January 22nd, 2026, 10:02

What Are the Purchase Channels for Cenobamat?

Cenobamat is a novel antiepileptic drug indicated for the treatment of partial-onset seizures in adults. Owing to...

Thursday, January 22nd, 2026, 09:58

Precautions for Cenobamate

Cenobamate, also known as Xcopri, is an anti-neurological drug used to treat partial neurological seizures. It...

Wednesday, July 2nd, 2025, 14:22

Departments

Oncology Hematology Immunology Hepatology Endocrinology Pulmonology Neurology Cardiology Gastroenterology Dermatology

Contact Medical Consultant

Global Drug Search

Clinical recruitment

overseas medical treatment

Remote consultation

Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.

Click to submit medical consultant

haiousales@gmail.com

Welcome To Consult